Estrogen
No increased risk for IBD flare 1 year after gender-affirming hormone therapy
PHILADELPHIA — Although there was no overall increased risk for flare 1 year after gender-affirming hormone therapy in patients with inflammatory bowel disease, active IBD and receiving testosterone increased the likelihood of a flare.
New therapies for vaginal menopause symptoms may provide short-term relief
Vaginal estrogen, vaginal dehydroepiandrosterone, oral ospemifene and vaginal moisturizers result in short-term improvements in vaginal atrophy symptoms, known as genitourinary syndrome of menopause, but more long-term data are needed.
Hyaluronic acid, estrogen yield similar improvements for vaginal atrophy
At 12 weeks, vaginal hyaluronic acid and vaginal estrogen were associated with similar benefits in the treatment of atrophic vaginitis, known as genitourinary syndrome of menopause, according to results of a pilot trial.
Headaches in Women
Type of menopausal hormone therapy may influence cancer risk
CHICAGO — Cancer risk among women varied based on the type of menopausal hormone therapy they used, according to randomized study results scheduled for presentation at ASCO Annual Meeting.
Reduced menopause symptoms with herbal supplement vs. hormone therapy
An oral herbal supplement with glucosinolates, phytosterols and citrus flavonoids was associated with some improved menopausal symptoms short term compared with estrogen plus progestogen therapy, researchers reported in Menopause.
The gut microbiome influences women’s health beyond digestive symptoms
This is the first installment of the Healio | Women’s Health & OB/GYN Nourish to Flourish column, edited by Susan Weiner, MS, RDN, CDN, CDCES, FADCES. In future installments, Weiner and Healio will speak with experts to discuss the impact of food and nutrients on women’s health.
Higher endometrial cancer, hyperplasia rates with conjugated estrogens/bazedoxifene
In the first years of use, women prescribed conjugated estrogens/bazedoxifene vs. estrogen/progestin for menopausal symptoms may have higher rates of endometrial cancer and endometrial hyperplasia but lower breast cancer rates.
Perioperative vaginal estrogen fails to reduce prolapse recurrence
Application of adjunctive perioperative vaginal estrogen failed to reduce prolapse recurrence after native tissue transvaginal prolapse repair compared with placebo, according to study results published in JAMA.
Migraine without aura may raise stroke risk in combined hormonal contraceptive users
Among combined hormonal contraceptive users, those with a history of migraine without aura had a significantly increased risk for ischemic stroke compared with those without a history of migraine, data show.